Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selatogrel PK Study in Healthy Subjects
NCT04557280Phase 1Completed
- Sponsor
- Viatris
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of selatogrel in acute myocardial infarction (AMI) (3 arms), sponsored by Viatris. Primary endpoints: Area under the plasma concentration-time curve (AUC0-t), Area under the plasma concentration-time curve (AUC0-inf) and 3 more. Started Nov 2020; status: completed.
02
Drugs
selatogrel
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT04557280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04557280.